Robert O'Neill

Can immune checkpoint inhibitors plus surgery cure advanced mismatch repair-deficient cancer?

Background There is a strong body of evidence supporting use of immune checkpoint inhibitors (ICI) in unresectable mismatch repair-deficient (MMRd) / microsatellite unst...

Ioanna Panagiotopoulou ;

Elizabeth Smyth ;

Harriet Baker ;

Hugo Ford ;

Robert O'Neill ;

06/27/2022

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

March 27 ⁠–⁠ March 30

See Full Calendar

Robert O'Neill

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products